Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

NCT00026221 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

NIH

Sponsor class

Conditions

Recurrent Melanoma
Stage IV Skin Melanoma

Interventions

BIOLOGICAL: Recombinant Interferon Alfa
BIOLOGICAL: Bevacizumab

Sponsor

National Cancer Institute (NCI)